1. Introduction {#s0005}
===============

Cancer is a highly prevalent chronic condition that is one of the leading causes of morbidity and mortality worldwide ([@b0095], [@b0120]). However, mortality rates have declined due to early diagnosis, enhanced surgical and radiotherapy techniques and improved systemic therapies ([@b0120]). Aside from these developments, breast cancer is still the second most common cause of death from cancer in women ([@b0050]). In Saudi Arabia, breast cancer is the most common cancer type among women; accounting for 27.3% of cancer cases among women ([@b0120], [@b0180], [@b0060]). Cancer diagnosis and treatment has shown to exhibit substantial impact on women's functional, mental and emotional well-being and overall quality of life ([@b0035]). Women with breast cancer commonly use complementary and alternative medicine (CAM); an estimated 44.7% of women with breast cancer reported using CAM ([@b0130], [@b0135]). CAM is defined by the National Centre for Complementary and Alternative Medicine (NCCAM) as "a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine" ([@b0085]).

There is an increasing demand for complementary therapies by cancer patients during their disease to reduce the side-effects of cancer therapy ([@b0160]). Women with breast cancer use CAM to boost their immunity ([@b0030]), prevent disease progression ([@b0105]), cure cancer ([@b0150]), or improve their quality of life ([@b0140]). The Quality of Life (QoL) may be described as the sense of well-being involving physical, mental, social and spiritual characteristics of an individual ([@b0035]). There is mixed evidence regarding the association between CAM and QoL. A Lebanese study reported no significant relation between CAM consumption and the patient's QoL ([@b0140]) that was consistent with the findings of a Malaysian study published in the same year ([@b0070]). On the other hand, a Korean study found a significant relationship between high CAM consumption and low QoL in breast cancer patients ([@b0105]).

The most common types of CAM used among women with breast cancer include spiritual therapy, a study using the National Health Interview Survey (NHIS) documented that yoga, chiropractic, and osteopathic manipulation are the most common CAM therapies used by cancer patients ([@b0145]). In Saudi Arabia, a cross-sectional study among 1,408 individuals reported that 62.5% of the participants used the Holy Quran ([@b0015]). Another was conducted among 518 participants, were prayers accounted for almost 54.0% of CAM, Hijama (wet cupping) 35.7% and cauterization or massage therapy 22% ([@b0075]).

There are few studies conducted in Saudi Arabia concerning CAM use among cancer patients ([@b0075], [@b0175], [@b0025]). In addition, there are no studies that examined the association between CAM and QoL among women with breast cancer in Saudi Arabia. Therefore, the purpose of this study was to examine the prevalence of CAM use and its' relation to the patients' quality of life among breast cancer women at a tertiary hospital in Saudi Arabia.

2. Methods {#s0010}
==========

2.1. Study Design {#s0015}
-----------------

A cross-sectional study was conducted among 140 women with breast cancer; 95 of women completed the questionnaire (Response rate 68%); 10 women did not complete the questionnaire, and 35 refused to participate.

2.2. Study Setting {#s0020}
------------------

The study was conducted in the females' Oncology ward among patients who attend their therapy from July 1^st^ to December 30^th^, 2016 at the Oncology Unit at a tertiary hospital in Saud Arabia.

2.3. Participants {#s0025}
-----------------

Women who participated in this study had the following inclusion criteria: females, eighteen years or older, diagnosed with breast cancer, and willing to take part in the study.

2.4. Procedures {#s0030}
---------------

A structured questionnaire was developed to measure CAM use and the factors that affect CAM use based on various studies ([@b0105], [@b0140], [@b0070], [@b0130], [@b0135]). The questionnaire was composed of three main sections (socio-demographic data, CAM use, and QoL). The questionnaire was approved by the Institutional Review Board (Ref.No. 16/0328/IRB). After receiving the IRB approval, the research assistant approached the eligible participants and began to explain the purpose of the study, reassured them about the flexibility of withdrawing and then obtained consent to start the interview. The interviewer then conducted a one to one interview using a structured questionnaire by reading the questions one by one and recording the participants' response.

2.5. Sample size {#s0035}
----------------

Based on previous studies ([@b0035], [@b0090], [@b0170]) we calculated the required sample size to be 76 patients through Jacob Cohens' table (Jacob [@b0110]) with an estimated power of 0.8, an alpha error of 0.05 and a medium effect size.

3. Measures {#s0040}
===========

3.1. Dependent variable {#s0045}
-----------------------

The dependent variable was CAM use since breast cancer diagnosis. Since diagnosis is described as the period from cancer diagnosis until the current date ([@b0130], [@b0135]). If patients did not use CAM, they were asked about the possible reasons for not using CAM. Patients who reported CAM use were asked about the reasons for CAM use, the frequency of CAM use, benefits and risks of CAM used, the cost of CAM, and the source of information about CAM. Participants were also asked if they have consulted their health care provider before using CAM, and the reasons for not consulting their healthcare provider.

3.2. Independent Variables {#s0050}
--------------------------

Independent variables include socio-demographic data (e.g. age, gender, marital status, occupation, education, and income level), Clinical data (e.g. ongoing cancer treatments), and Quality of life (QoL). QoL was assessed using a validated ([@b0100], [@b0185], [@b0040]) Arabic version of the European Organization for Research and Treatment of Cancer (EORTC) ([@b0005]). We used the generic EORTC-QLQ-C30 and cancer specific EORTC QLQ-BR23 QoL questionnaires. The generic QoL scale consists of 30-items that contain both multi and single-item scales that measure the cancer patient's QoL ([@b0005]). The breast cancer QoL scale, on the other hand, consists of 23 items that measure the breast cancer patient's QoL using five subscales (treatment side effects, arm symptoms, breast symptoms, body image, and sexual function).

The EORTC questionnaire scale scores range from 0 to 100; greater scores in the functional scale and QoL indicate a superior degree of performance and QoL. However, greater scores on a symptom scale refer to a critical degree of symptoms ([@b0005]).

4. Analysis Plan {#s0055}
================

Descriptive and inferential statistics were used to describe our sample. The correlation was used to assess the association between CAM use and QoL. Adjusted binary logistic regression was used to examine the factors affecting CAM use. Statistical Package for the Social Sciences (SPSS) version 24.0 was used for the analysis.

5. Results {#s0060}
==========

5.1. Description of the study sample {#s0065}
------------------------------------

The characteristics of the study participants are summarized in [Table 1](#t0005){ref-type="table"}. All participants were women; almost half of the study sample was between 40-59 years of age. The majority of the patients were Saudi, 70% resided in Riyadh, 76% were married, 84% were unemployed, and 57% reported low income (i.e., income level below 5000 Saudi Riyals). Furthermore, 89% of study participants were undergoing cancer treatment.Table 1Description of the study sample.**N%Age**25-392526.340-594547.460 and above2526.3**Nationality**Saudi7781.1None-Saudi1818.9ResidenceRiyadh6770.5Other2829.5**Level of education**Uneducated1920.0\<High school level4951.6\>High school level2728.4**Social status**Married7275.8Unmarried2324.2**Job Status**Employed1515.8Unemployed8084.2**Average monthly income**\< 5000 SR5557.95000-10000 SR2425.3\>10000 SR1616.8**Ongoing cancer treatment**Yes8589.5No1010.5[^1][^2]

5.2. Description of the study sample by CAM use {#s0070}
-----------------------------------------------

Current CAM use was reported by 81.1% of study participants ([Table 2](#t0010){ref-type="table"}). Our study found that there is a statistically significant difference between CAM users and non-users in employment. A significantly higher percentage of CAM users were employed as compared to non-CAM users (80% vs. 20%). We did not find statistically significant differences between CAM users and non-CAM users in age, nationality, residence, educational status and other variables. We found that women who underwent cancer treatment had a significantly higher percentage of CAM use as compared to those who did not undergo cancer therapy (72.6% vs. 8.4%, p=0.008).Table 2Description of the study sample by CAM use.**CAM UseNo CAM UseN%N%Sig**Total957781.11818.9**Age**25-39252080.0520.00.19240-59453680.0920.060 and above252184.0416.0**Nationality**Saudi776483.11316.91.128None-Saudi181372.2527.8**Residence**Riyadh675379.11420.90.562Other282485.7414.3**Which area**Middle302790.0310.02.286Other regions655076.91523.1**Level of education**Uneducated191684.2315.80.323\<high school level494081.6918.4\>high school level272177.8622.2**Social status**Married725779.21520.80.689Single / Divorced / Widowed232087.0313.0**Job Status**Employed151280.0320.00.013\*\*Unemployed806581.31518.8**Average monthly income**\< 5000 SR554581.81018.20.077\*\*5000-10000 SR241979.2520.8\>10000 SR161381.3318.8**Ongoing cancer treatment**Yes856972.61616.80.008\*\*No1088.4022.1[^3][^4]

5.3. Factors that affect CAM Use {#s0075}
--------------------------------

[Table 3](#t0015){ref-type="table"} displays the reasons for CAM use among study participants. The commonly reported source of information about CAM was family and friends (54.7%) followed by the Media (20%). Around 42% of the participant's self-chosen their CAM and 37.9% chose it according to the recommendations of family or friends. Family and friends were reported to be the common CAM providers (45.3%). CAM usage was reported to be more than once per month (65.3%), and 78.9% of the consumers spent approximately less than 500 SR per month on CAM.Table 3Prevalence and characteristics of CAM use.**N%CAM use since diagnosis**Yes7781.1No1818.9**Source of Information about CAM**No one66.3Media1920.0Internet1818.9Family / Friends5254.7Doctor11.1Other1111.6**How CAM was chosen**Self-choice4042.1Family / Friends3637.9Health Specialist66.3Social media1111.6**Frequency of CAM use**Once a month1515.8\> Once month6265.3**CAM provider**No one2223.2Doctor33.2Family / Friends4345.3Other1010.5**Approximate cost per month**\<500 SR7578.9\>500 SR2021.1**Reason for CAM use after diagnosis**Directly eliminate cancer2829.5Increase immunity3536.8Improve physical & psychological well being3738.9Benefit and no harm2425.3Do everything they can to fight cancer3536.8**Benefits acquired from CAM usage**No benefit1313.7Direct decrease in cancer cells1717.9Increased immunity2122.1Improved physical & psychological well being5658.9Decrease in treatment side effects1616.8Other11.1**CAM side effects**Yes88.4No6972.6**Satisfaction with CAM**Satisfied3637.9Average3334.7Dissatisfied88.4**Extent of CAM effectiveness**Effective4345.3Average2829.5Not effective66.3**Consult Doctor about CAM use**Yes3334.7No4446.3**Reason for not consulting the doctor**Did not think it was important3233.7Fear of receiving negative input44.2Other88.4[^5][^6]

The frequently cited reasons for using CAM was to improve physical & psychological well-being (38.9%), strengthen the immune system (36.8%) and directly eliminate cancer (29.5%). The benefits reported from CAM usage were to improve physical & psychological well-being (58.9%) and increase immunity (22.1%).

The majority of CAM users (72.6%) did not experience side effects, 37.9% stated that they were satisfied with their CAM use and 45.3% reported CAM to be effective. Higher proportions (46.3%) of CAM users did not discuss their use of CAM with their physicians. The main reason for not discussing CAM consumption with their physicians was because they did not think it was important to consult their physician (33.7%), and others feared to receive negative input (4.2%). [Table 4](#t0020){ref-type="table"} illustrated the most common types of CAM used after cancer diagnosis as follow: Spiritual therapy 70.5%, followed by Honey 36.8%, Olive oil 24.2% and 23.2% used Herbal therapy.Table 4Type of CAM use after diagnosis.***N*****%**None11.1Spiritual therapy6770.5Herbal Therapy2223.2Hojama1111.6Black seed1616.8Honey3536.8Olive oil2324.2Other2223.2[^7][^8]

6. Association between CAM Use and Quality of Life {#s0080}
==================================================

[Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"} display the mean value for each subscale of both the EORTC QLQ-C30 and EORTC QLQ-BR23 questionnaires. In the EORTC QLQ-C30*,* statistical differences were found between CAM users and non-CAM users in the mean global health status (73.16 vs. 64.82, p-value 0.049), physical function (68.05 vs. 63.33, p-value 0.055), role function (78.14 vs. 62.96, p-value 0.002) and social function (83.33 vs. 72.22, p-value 0.047). Furthermore, only constipation (29.01 vs. 14.81, p-value 0.005) from the symptoms scale was significantly different between CAM users and non-CAM users.Table 5Association between CAM Use and Quality of Life EORTC QLQ-C30.**CAM UsersNon-CAM UsersEORTC QLQ-C30**Mean ± SDMean ± SDP-value*Global health status QoL*73.16 ± 20.2664.82 ± 32.790.049\*\**Functional Scale*Physical68.05 ± 21.7263.33 ± 28.020.055\*\*Role78.14 ± 29.2862.96 ± 42.230.002\*\*Emotional70.78 ± 29.5467.14 ± 32.390.733Cognitive79.22 ± 24.0583.33 ± 25.560.934Social83.33 ± 26.3572.22 ± 33.820.047\*\**Symptom Scale*Fatigue33.62 ± 29.1341.97 ± 30.390.729Nausea & Vomiting19.70 ± 30.5512.04 ± 26.070.200Pain33.99 ± 31.4650.92 ± 28.850.424Dyspnea25.11 ± 30.1924.07 ± 29.830.614Insomnia48.06 ± 41.0140.74 ± 46.520.249Appetite Loss31.60 ± 34.5929.63 ± 41.050.151Constipation29.01 ± 39.1314.81 ± 28.520.005\*\*Diarrhea12.99 ± 28.6918.52 ± 38.300.133Financial difficulties13.42 ± 29.2520.37 ± 34.560.264[^9][^10]Table 6Association between CAM Use and Quality of Life EORTC QLQ-BR23.**CAM UsersNon-CAM UsersEORTC QLQ-BR23**Mean ± SDMean ± SDP-value*Functional ScaleBody Image*80.63 ± 23.4066.67 ± 34.780.005\*\*Sexual Functioning19.26 ± 25.2325.93 ± 31.430.213Sexual Enjoyment21.33 ± 28.8124.08 ± 33.940.211Future Perspective64.07 ± 38.5355.55 ± 41.230.541*Symptom Scale*Systemic therapy Side Effects25.98 ± 19.6726.14 ± 27.410.119*Breast Symptoms*22.73 ± 21.6223.15 ± 23.331.000Arm Symptoms37.36 ± 28.3936.42 ± 29.970.760Upset by hair loss34.85 ± 41.8951.86 ± 44.450.790[^11][^12]

For the EORTC QLQ-BR23 subscales, we only observed a significant variation between CAM users and non-CAM users in body image (80.63 vs. 66.67, p-value 0.049), as for the rest of the questionnaire subscales, there were no significant differences found.

7. Sociodemographic and cancer related factors affecting CAM use {#s0085}
================================================================

[Table 7](#t0035){ref-type="table"} displays the adjusted analysis of CAM use. The sociodemographic factors have not been found to affect the patient's CAM consumption.Table 7Sociodemographic and cancer related factors affecting CAM use.**BS.E.Sig.95% C.I.LowerUpper**Age0.010.460.980.412.48Nationality0.080.720.910.274.42Residence-0.600.690.390.142.16Level of education0.050.520.930.382.92Social status-0.450.750.550.152.78Job Status-0.070.870.940.175.15Average monthly income-0.010.410.980.442.21Ongoing cancer therapy-0.050.890.900.175.43[^13][^14]

8. Discussion {#s0090}
=============

In this cross-sectional study, breast cancer women from various backgrounds were examined for their CAM use and its' relation to the patients' QoL. The higher rate of CAM use among women with breast cancer in our study sample (81%) is consistent with other studies conducted in Korea 67% ([@b0105]), Saudi Arabia 74% ([@b0020]), and Ethiopia 79% ([@b0080]). Other studies have reported a lower rate of CAM use, 40% in a Lebanese study ([@b0140]), 51% in Malaysian study ([@b0170]) and approximately 57% in a Turkish study ([@b0190]).

CAM use in our study population was affected by many factors such as employment, average monthly income, and ongoing anti-cancer therapy. These findings are consistent with published studies in the wider literature ([@b0090], [@b0020], [@b0065], [@b0010]). The high prevalence of CAM usage found in our study could be justified by the strong religious and cultural beliefs among our population. Also, many women in this study reported using CAM to improve their physical & psychological wellbeing, and immune function were the commonly listed reasons, which was in agreement with other studies conducted by Almousa et al. ([@b0105]) and Saibul et al. ([@b0170]). Other studies reported other reasons for using CAM such as perceived benefits of CAM ([@b0080]), to improve their functional and emotional well-being ([@b0065]).

Furthermore, women in this study may have used CAM to improve their QoL. In fact, this study found that CAM users have a higher QoL as compared to non-users. The study findings displayed significantly enhanced physical, role and social functions among CAM users, yet, they were more likely to suffer from constipation and were found to be more concerned about their body image as compared to non-CAM users. In earlier studies ([@b0190]), significant differences were only noted in terms of role and emotional functioning in addition to dyspnea and appetite loss. However, studies conducted in Ethiopia, Turkey, and Malaysia found no difference in QoL between CAM users and non-users ([@b0070], [@b0080], [@b0190]).

The commonly reported source of information about CAM was "family and friends", which was consistent with various studies ([@b0030], [@b0105], [@b0080], [@b0010]). CAM users in our study did not experience side effects of CAM ([@b0030], [@b0140], [@b0080], [@b0010]), and CAM users were satisfied with their CAM use ([@b0030], [@b0140], [@b0190]). As mentioned in earlier findings ([@b0105], [@b0140], [@b0080], [@b0045]), higher proportions of CAM users in our study did not discuss CAM use with their physicians mainly because they "did not think it was important" ([@b0105]) and others feared to receive negative input ([@b0080]). Roter et al. have found that the majority of CAM discussion in the oncology setting is initiated by the patients rather than physicians ([@b0165]). In this study, the most common type of CAM used was Spiritual therapy 70.5% ([@b0065]). This high percentage could be explained by the strong religious beliefs of participants who are Muslim. In addition, the other modalities of CAM such as Honey (36.8%), Olive oil (24.2%) and herbal therapy (23.2%) were also used among the study population. Nevertheless, herbal therapy took the lead in previously conducted studies from various locations ([@b0015], [@b0075], [@b0190], [@b0010], [@b0155], [@b0055]). In Saudi Arabia ([@b0015], [@b0075]), Jordan ([@b0010]), and similarly in the UK ([@b0155]), herbal medicine were among the highest percentages of most common type of CAM consumed. Natural products are readily available and often sold as dietary supplements. They include a range of herbs, vitamins, minerals, and probiotics ([@b0145]). Although the benefits of many natural products have been documented, there is still a lot to be learned about their effects on the human body, their safety and potential interactions with medicines and other natural products ([@b0125], [@b0115]).

9. Strengths and limitations {#s0095}
============================

This study was the first to investigate the association of CAM utilization with QoL amongst women with breast cancer in Saudi Arabia. However, this study has some limitations. All measures in the study were self-reported and hence subject to recall bias. Also, this study was conducted among women with breast cancer in a tertiary hospital in Saudi Arabia in an oncology clinic; therefore, our findings cannot be generalizable to other settings or other types of cancer.

10. Conclusion {#s0100}
==============

CAM therapy commonly used among women in our study sample was correlated with higher overall global QoL, better physical, role and social functions and had a greater concern about their body images as compared to non-CAM users. Employment status and average monthly income, as well as ongoing anti-cancer therapy, had a significant relationship with CAM use. Since CAM is commonly widely used nowadays, the healthcare team may need to discuss the use of CAM with breast cancer women and be up to date on the benefits and risk of CAM use through well-equipped training programs and workshops. Also, future studies may need to explore the factors behind the patients' CAM utilization.
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